OSOliver Stumper

Oliver Stumper

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Oliver Stumper has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Stenting of the right ventricular outflow tract as primary palliation for Fallot-type lesions

    by D. Quandt, G. Penford, B. Ramchandani, V. Bhole, C. Mehta, O. Stumper


  • Open Access

    Catheter hemodynamic assessment of the univentricular circulation

    by Oliver Stumper, Gemma Penford

    Children with very complex congenital heart disease not amenable to biventricular repair are increasingly being considered for a palliative univentricular care pathway. This involves a staged surgical approach culminating in the Fontan circulation with passive pulmonary blood flow and added resistances. The catheter based hemodynamic assessment at all three stages of this palliation is described in detail. Frequent pitfalls, inherent limitations and potential errors are discussed and clinical examples are illustrated.


  • Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome

    by Patrick Noonan, Vikram Kudumula, Ben Anderson, Bharat Ramchandani, Paul Miller, Rami Dhillon, Chetan Mehta, Oliver Stumper

    Background: Left pulmonary artery stenosis and hypoplasia is a well‐recognized complication following surgical palliation of hypoplastic left heart syndrome. These lesions produce increased after load in a circulation in series so need to be effectively treated.Methods: Between 2000 and 2011, 86 patients after surgical palliation for hypoplastic left heart syndrome had left pulmonary artery stents implanted. Median age at implantation was 4.7(1.3–15.2) years and median weight was 16.4(9.3–55.2) kg. Uncovered peripheral vascular stents were implanted (median diameter 10(8–15) mm). This is a retrospective review of the incidence of in‐stent restenosis over the medium to long term.Results: During primary stenting procedures, there were 2/88(2.3%) major complications of stent migration with no stroke or mortality. Follow‐up was for a median period of 4.1(0.5–13.4) years. Follow‐up catheter procedures were performed after a median time of 2.3(0.02–9.6) years in 59 patients (68.6%). 55/59(93.2%) had at most mild restenosis (≤10% loss of stent lumen) and 47/59(79.6%) had no evidence of any restenosis at all caused by neointimal in‐growth. Freedom from reintervention was 77% at 5 years including stent dilation to compensate for somatic growth. Freedom from reintervention for restenosis was 93% at 5 years. Restenosis was successfully treated with standard balloon angioplasty or restenting. There was only 1/94 (1.1%) major complication in the follow‐up catheterizations of stent embolization with successful transcatheter retrieval.Conclusions: Stenting of the left pulmonary artery after Norwood/Fontan palliation is safe and effective. Stents can be redilated to match somatic growth. The incidence of neointimal proliferation is extremely low and can be addressed by balloon dilation or stent implantation.


  • Restrictive atrial septum after the Fontan procedure

    by Gemma Penford, Daniel Quandt, Oliver Stumper

    In this study, three patients presenting with early or late postoperative Fontan complications were identified to suffer from restriction of the native atrial septum. This caused significant obstruction to pulmonary venous return and elevated systemic venous pressure. Dobutamine stress testing was used in one patient to identify this lesion. Transcatheter stenting was performed in the other two patients. Patients improved after relief of the obstruction.


  • Open Access

    Initial experience with the cook formula balloon expandable stent in congenital heart disease

    by Daniel Quandt, Bharat Ramchandani, Vinay Bhole, Gemma Penford, Chetan Mehta, Rami Dhillon, Oliver Stumper

    Introduction: Balloon expandable stents are an integral part in the catheter treatment of congenital heart disease. In the growing child, stents require dilatation to greater diameters over time. The Cook Formula stent is a recent 316 stainless steel open‐cell design licensed for peripheral vascular work.Methods: Following extensive ex vivo studies, 112 stents were implanted in 97 children [median age 3.9 (0.01–17.6) years; median weight 13.7 (2.4–62.8) kg] over a 27‐month (Oct 2011–Dec 2013) period.Results: Bench testing revealed that there was no stent shortening for dilatation to nominal diameter and beyond. The 5 mm stents could be dilated up to 10 mm, and the 10 mm stents to 20 mm. Stents were implanted through 4–7F sheaths or guide catheters over appropriate wires. Stent tracking and delivery was excellent. Twenty‐three stents were implanted in the right ventricular outflow tract in Fallot‐type lesions, 53 for branch pulmonary artery stenosis (22 post cavopulmonary shunt/Fontan), 14 conduit stenosis, 13 Fontan fenestrations, 3 PDA in hybrid stage I Norwood, 5 in coarctation, and 1 for SVC obstruction. Sixty‐one stents (54%) were overdilated. There were no stent fractures. Radial strength was very good, whereas stent conformability was limited.Conclusions: The Cook Formula stent is a premounted balloon‐expandable stent that can be significantly overdilated with virtually no shortening allowing for precise placement and minimal protrusion into adjacent vessels. The Formula stent is a very versatile addition to the range of stents for use in the catheter treatment of complex congenital heart disease in children.


  • Open Access

    Transcatheter device closure of a traumatic ventricular septal defect

    by Oliver Stumper, Mohamed Kasem, HariKrishnan Kanthimathinathan, Chetan Mehta, Richard Neal

    A traumatic ventricular septal defect (VSD) resulting from blunt chest injury is a very rare event in children. The clinical symptoms and timing of presentation are variable, so diagnosis and management of traumatic VSD may be challenging. Decision to close the traumatic VSD is usually based on a combination of severity of heart failure symptoms, hemodynamics, and defect size. We present a case of a 7-year-old boy who was run over by a truck and presented with head and liver injury initially. He was subsequently found to have a traumatic VSD. The VSD was closed percutaneously.


  • Non-invasive cardiac output monitoring during catheter interventions in patients with cavopulmonary circulations

    by Patrick Michael Emmet Noonan, Sangeetha Viswanathan, Amy Chambers, Oliver Stumper

    Introduction: Functionally univentricular hearts palliated with superior or total cavopulmonary connection result in circulations in series. The absence of a pre-pulmonary pump means that cardiac output is more difficult to adjust and control. Continuous monitoring of cardiac output is crucial during cardiac catheter interventions and can provide new insights into the complex physiology of these lesions. Materials and methods: The Icon® cardiac output monitor was used to study the changes in cardiac output during catheter interventions in 15 patients (median age: 6.1 years, range: 4.8–15.3 years; median weight: 18.5 kg, range: 15–63 kg) with cavopulmonary circulations. A total of 19 interventions were undertaken in these patients and the observed changes in cardiac output were recorded and analysed. Results: Cardiac output was increased with creation of stent fenestrations after total cavopulmonary connection (median increase of 22.2, range: 6.7%–28.6%) and also with drainage of significant pleural effusions (16.7% increase). Cardiac output was decreased with complete or partial occlusion of fenestrations (median decrease of 10.6, range: 7.1%–13.4%). There was a consistent increase in cardiac output with stenting of obstructive left pulmonary artery lesions (median increase of 7.7, range: 5%–14.3%, p = 0.007). Conclusions: Icon® provides a novel technique for the continuous, non-invasive monitoring of cardiac output. It provides a further adjunct for monitoring of physiologically complex patients during catheter interventions. These results are consistent with previously reported series involving manipulation of fenestrations. This is the first report identifying an increase in cardiac output with stenting of obstructive pulmonary arterial lesions.


  • Open Access

    Catheter rehabilitation of occluded aberrant pulmonary artery

    by Patrick M.E. Noonan, Bharat Ramchandani, David J. Barron, Oliver Stumper

    A 10-year old girl underwent a CT angiogram to investigate right lung hypoplasia. This showed a normal bronchial tree, lung parenchyma and pulmonary venous drainage, but an absent right pulmonary artery. Cardiac catheterization with pulmonary vein wedge injections identified a disconnected hypoplastic right pulmonary artery system supplied by an occluded right-sided ductus arteriosus. Transcatheter recanalization of the ductus re-established right pulmonary artery flow and growth. Ultimately, this allowed for complete surgical repair and restoration of normal perfusion of the right lung, leading to complete functional rehabilitation.


  • Catheter interventions in the staged management of hypoplastic left heart syndrome

    by Zdenka Reinhardt, Joseph De Giovanni, John Stickley, Vinay K. Bhole, Benjamin Anderson, Bari Murtuza, Chetan Mehta, Paul Miller, Rami Dhillon, Oliver Stumper

    Aim: To analyse the current practice and contribution of catheter interventions in the staged management of patients with hypoplastic left heart syndrome.Methods: This study is a retrospective case note review of 527 patients undergoing staged Norwood/Fontan palliation at a single centre between 1993 and 2010. Indications and type of catheter interventions were reviewed over a median follow-up period of 7.5 years.Results: A staged Norwood/Fontan palliation for hypoplastic left heart syndrome was performed in 527 patients. The 30-day survival rate after individual stages was 76.5% at Stage I, 96.3% at Stage II, and 99.4% at Stage III. A total of 348 interventions were performed in 189 out of 527 patients. Freedom from catheter intervention in survivors was 58.2% before Stage II and 46.7% before Stage III. Kaplan–Meier freedom from intervention post Fontan completion was 55% at 10.8 years of follow-up. Post-stage I interventions were mostly directed to relieve aortic arch obstruction – 84 balloon angioplasties – and augment pulmonary blood flow – 15 right ventricle-to-pulmonary conduit interventions; post-Stage II interventions centred on augmenting size of the left pulmonary artery – 73 procedures and abolishing systemic venous collaterals – 32 procedures. After Stage III, the focus was on manipulating the size of the fenestration – 42 interventions – and the left pulmonary artery −31 procedures.Conclusion: Interventional cardiac catheterisation constitutes an integral part in the staged palliative management of patients with hypoplastic left heart syndrome. Over one-third (37%) of patients undergoing staged palliation required catheter intervention over the follow-up period.